149 related articles for article (PubMed ID: 33344246)
41. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
Yao Y; Chen R; Wang G; Zhang Y; Liu F
Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
[TBL] [Abstract][Full Text] [Related]
42. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
43. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
44. Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer.
Chen HY; Chiang YF; Huang JS; Huang TC; Shih YH; Wang KL; Ali M; Hong YH; Shieh TM; Hsia SM
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799801
[TBL] [Abstract][Full Text] [Related]
45. Lnc-LFAR1 affects intrahepatic cholangiocarcinoma proliferation, invasion, and EMT by regulating the TGFβ/Smad signaling pathway.
Chen C; Li H; Wang X; Wang L; Zeng Q
Int J Clin Exp Pathol; 2019; 12(7):2455-2461. PubMed ID: 31934072
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression.
Li C; Song L; Zhang Z; Bai XX; Cui MF; Ma LJ
Oncotarget; 2016 Oct; 7(41):66989-67003. PubMed ID: 27611950
[TBL] [Abstract][Full Text] [Related]
47. Oridonin inhibits pancreatic cancer cell migration and epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling pathway.
Liu QQ; Chen K; Ye Q; Jiang XH; Sun YW
Cancer Cell Int; 2016; 16():57. PubMed ID: 27453691
[TBL] [Abstract][Full Text] [Related]
48. Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma.
Deng G; Chen L; Zhang Y; Fan S; Li W; Lu J; Chen X
Exp Cell Res; 2018 Sep; 370(2):613-622. PubMed ID: 30031128
[TBL] [Abstract][Full Text] [Related]
49. Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.
Zhang L; Li Z; He W; Xu L; Wang J; Shi J; Sheng M
Cell Physiol Biochem; 2015; 37(1):43-54. PubMed ID: 26278416
[TBL] [Abstract][Full Text] [Related]
50. Total flavone of
Yang BL; Zhu P; Li YR; Xu MM; Wang H; Qiao LC; Xu HX; Chen HJ
World J Gastroenterol; 2018 Aug; 24(30):3414-3425. PubMed ID: 30122880
[TBL] [Abstract][Full Text] [Related]
51. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
52. Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions.
Kim YS; Jung DH; Kim NH; Lee YM; Kim JS
Eur J Pharmacol; 2007 May; 562(1-2):12-9. PubMed ID: 17321517
[TBL] [Abstract][Full Text] [Related]
53. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
54. Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P
Oncotarget; 2016 Nov; 7(44):71341-71352. PubMed ID: 27533085
[TBL] [Abstract][Full Text] [Related]
55. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-β signaling pathway.
Guo Y; Cui W; Pei Y; Xu D
Gynecol Oncol; 2019 Jun; 153(3):639-650. PubMed ID: 30928020
[TBL] [Abstract][Full Text] [Related]
56. Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma.
Lv W; Wang J; Zhang S
Oncol Lett; 2019 Nov; 18(5):5325-5331. PubMed ID: 31612042
[TBL] [Abstract][Full Text] [Related]
57. Methyl-CpG-binding domain 3 inhibits epithelial-mesenchymal transition in pancreatic cancer cells via TGF-β/Smad signalling.
Xu M; He J; Li J; Feng W; Zhou H; Wei H; Zhou M; Lu Y; Zeng J; Peng W; Du F; Gong A
Br J Cancer; 2017 Jan; 116(1):91-99. PubMed ID: 27898661
[TBL] [Abstract][Full Text] [Related]
58. Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo.
Cheng H; Lu C; Tang R; Pan Y; Bao S; Qiu Y; Xie M
Oncotarget; 2017 Feb; 8(7):12301-12310. PubMed ID: 28135203
[TBL] [Abstract][Full Text] [Related]
59. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
60. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
